 comparison tobramycin interv treatment pulmonari exacerb cystic fibrosi patient efficaci toxic shorten tobramycin interv treatment exacerb pseudomona pulmonari infect cystic fibrosi patient patient year treatment cours pair tobramycin hour peak serum concentr micrograms/ml total daili dosag patient tobramycin hour shorter interv pulmonari function follow-up time next hospit admiss pulmonari exacerb studi hospit differ pulmonari function test clinic score sputum carriag aeruginosa toxic necessari length hospit tobramycin interv efficaci dose interv treatment cystic fibrosi patient